Building the Future Management of Follicular ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
Auteur(s) :
Iacoboni, Gloria [Auteur]
Vall d'Hebron Institute of Oncology [Barcelone] [VHIO]
Morschhauser, Franck [Auteur]
Université de Lille
Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365
Vall d'Hebron Institute of Oncology [Barcelone] [VHIO]
Morschhauser, Franck [Auteur]

Université de Lille
Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365
Titre de la revue :
Blood
Éditeur :
American Society of Hematology
Date de publication :
2024-11-14
ISSN :
1528-0020
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the ...
Lire la suite >Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the relapsed/refractory setting have the potential to improve outcomes and change the treatment algorithm in FL. This review focuses on the role of chimeric antigen receptor T-cells and bispecific antibodies in FL, paying special attention to sequencing approaches and future directions.Lire moins >
Lire la suite >Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the relapsed/refractory setting have the potential to improve outcomes and change the treatment algorithm in FL. This review focuses on the role of chimeric antigen receptor T-cells and bispecific antibodies in FL, paying special attention to sequencing approaches and future directions.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
CHU Lille
CHU Lille
Collections :
Date de dépôt :
2024-12-08T22:01:51Z
2024-12-20T13:13:00Z
2024-12-20T13:13:00Z